In KRAS mutant colon cancer cells, SLC25A22 promotes the accumulation of succinic acid, a metabolite of glutamine in the tricarboxylic acid cycle, which further increases the local methylation degree of DNA and then promotes the activation of Wnt signaling pathway. Here, KRAS is linked to malignant colon neoplasm.